TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Swedish registry study of nearly 1.46 million children found that parental autoimmune disease was associated with higher offspring risk of type 1 diabetes. The association was strongest when a parent had type 1 diabetes, but the observational findings do not establish cause and may not apply equally across populations.
A Swedish study of 1,455,645 children found that those whose parents had autoimmune diseases were more likely to develop type 1 diabetes, with the strongest associations among children whose mother or father had type 1 diabetes. The findings, published in JAMA Pediatrics, describe a link in registry data; they do not show that a parent’s condition caused diabetes in a child.
Children whose mothers had an autoimmune disease before delivery had a 57% higher estimated risk of type 1 diabetes than children whose mothers did not, based on an adjusted hazard ratio (HR) of 1.57 (95% confidence interval, 1.46-1.68). The association for paternal autoimmune disease before childbirth was similar: HR 1.51 (95% CI, 1.37-1.67). These estimates covered autoimmune diseases as a group, not only type 1 diabetes.
The associations were larger when the parent had type 1 diabetes. Maternal type 1 diabetes was linked with an HR of 4.51 (95% CI, 3.72-5.48), while paternal type 1 diabetes was linked with an HR of 5.79 (95% CI, 4.70-7.13). An HR compares the rate of an outcome over time between groups; it is not, by itself, a child’s absolute probability of developing the disease.
The children were born in Sweden from 2001 through 2014 and followed through 2023. Their median age at the end of follow-up was 15.3 years. In analyses designed to account for shared family factors, the association with maternal autoimmune disease remained, though it was smaller: HR 1.27 (95% CI, 1.08-1.50). The researchers reported variation by disease category, with stronger paternal associations for endocrine conditions—especially autoimmune thyroiditis—and stronger maternal associations for ankylosing spondylitis and gastrointestinal autoimmune disorders.
What the Familial Risk Pattern Shows
The results add large-scale evidence that a child’s risk of type 1 diabetes is associated with autoimmune disease in either parent, not just with maternal illness during pregnancy. The broadly similar overall maternal and paternal estimates are consistent with a role for shared familial susceptibility, including inherited factors. The study cannot determine how much of the association comes from genes, shared environment, pregnancy-related influences, or other factors.
For families, the findings may help clinicians identify children who warrant discussion about risk and possible screening. In an accompanying editorial, Mikael Knip of Biomedicum Helsinki said children of parents with autoimmune disease should be monitored, while noting that screening practices can vary with available resources. A higher relative risk does not mean that a particular child will develop diabetes, and the study does not set out an individual prediction or screening schedule.
Early identification is a point raised by clinicians because recognition before clinical illness may affect care. However, this report does not test a screening program or show that monitoring these children improves outcomes. Decisions about testing should be made with qualified health professionals, taking account of a child’s family history and local clinical guidance.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Garmin Forerunner 55 GPS Running Smartwatch, Black
Levoit Core 300S-P Smart WiFi Air Purifier
As an affiliate, we earn on qualifying purchases.
How Researchers Compared Families
Researchers used Swedish registry records to identify children, parental diagnoses and subsequent type 1 diabetes diagnoses. The study included 6.1% of children exposed to maternal autoimmune disease before delivery. The team also used cousin-comparison models to address some unmeasured factors shared within families. In that analysis, the maternal association remained statistically significant but was weaker than the initial estimate.
The study’s authors said the highest risk was among offspring with both parents affected by type 1 diabetes, describing a gradient according to parental type 1 diabetes status. The supplied report does not give a numerical estimate for that subgroup. The findings fit a multifactorial model: type 1 diabetes risk is not inherited in a simple, single-gene pattern, and parental diagnosis alone cannot determine whether a child will develop the condition.
Benjamin Nwosu, a pediatric endocrinologist at Northwell Health Cohen Children’s Medical Center who was not involved in the study, said genetic factors also matter. He noted that the report did not discuss the contribution of major histocompatibility complex class 2 genes, which he said carry a substantial share of type 1 diabetes risk. His comments provide clinical context, rather than a result measured by this study.
“A clear gradient in type 1 diabetes risk was observed according to parental type 1 diabetes status, with the highest risk among offspring with both parents affected.”
— Xingbo Mo, PhD, and colleagues, the study authors
Limits on Interpreting the Findings
The study was observational, so it identifies associations rather than showing that autoimmune disease in a parent directly causes type 1 diabetes in a child. Registry data also did not capture clinical disease severity, autoantibody levels, disease activity during pregnancy or medication use. The authors said these factors could affect fetal immune programming but could not be evaluated.
The results come from children in Sweden, and their relevance elsewhere is uncertain. Nwosu cautioned that Sweden’s northern latitude may limit how readily the findings translate to other populations. The study also does not establish an absolute risk for an individual child, explain the biological mechanism behind each disease-specific difference, or show whether screening based on parental autoimmune disease changes health outcomes.
How Screening Guidance May Evolve
The report does not announce a new screening recommendation or specify a follow-up schedule. Knip pointed to existing consensus guidance for screening and monitoring people considered at risk, while noting that implementation can depend on available resources. Families and clinicians will need to use applicable local guidance rather than treating the study’s relative-risk estimates as a standalone testing rule.
Further research would be needed to clarify how disease activity, treatment, antibodies and inherited factors contribute to the associations, and to test whether monitoring children identified through parental history improves outcomes. For now, the confirmed development is a large Swedish cohort report of increased relative risk; how the evidence should change routine practice remains unsettled.
Key Questions
Does a parent’s autoimmune disease mean a child will develop type 1 diabetes?
No. The study found an association across a population, not a certainty for any individual child. Parental disease is one factor among several, and the report does not calculate a child’s personal probability.
Which parental condition had the strongest association?
Among the conditions reported, parental type 1 diabetes had the largest estimates: HR 4.51 for maternal type 1 diabetes and HR 5.79 for paternal type 1 diabetes. These are relative hazard estimates, not absolute chances of disease.
Did the study prove that autoimmune disease during pregnancy causes diabetes?
No. The observational study found associations and cannot establish cause. Researchers also lacked data on disease activity during pregnancy, medication use, severity and autoantibody levels.
Should every child with a parent who has an autoimmune disease be screened?
The study does not issue a screening rule or schedule. An accompanying editorial discussed existing consensus guidance for people at risk. Families should ask a qualified health professional how current local recommendations apply to their circumstances.
Source: medpagetoday.com
